2011 annual financial data

Neuphoria Therapeutics 2011 Operating margin

Direct answer

Operating margin was -308.11%.

Operating income was -10.48M USD and net income was -10M USD.
Operating cash flow was -7.9M USD.

Get free Neuphoria Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
3.4M USD
Operating income
-10.48M USD
Net income
-10M USD
Operating cash flow
-7.9M USD